Optimal Glycemic Control, Pre-eclampsia, and Gestational Hypertension in Women With Type 1 Diabetes in the Diabetes and Pre-eclampsia Intervention Trial
Open accessThe DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the relationship between glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes. RESEARCH DESIGN AND METHODS: Pregnancy outcome (pre-eclampsia or gestational hypertension) was assessed prospectively in 749 women from the randomized controlled Diabetes and Pre-eclampsia Intervention Trial (DAPIT). HbA(1c) (A1C) values were available up to 6 months before pregnancy (n = 542), at the first antenatal visit (median 9 weeks) (n = 721), at 26 weeks' gestation (n = 592), and at 34 weeks' gestation (n = 519) and were categorized as optimal (<6.1%: referent), good (6.1-6.9%), moderate (7.0-7.9%), and poor (≥8.0%) glycemic control, respectively. RESULTS: Pre-eclampsia and gestational hypertension developed in 17 and 11% of pregnancies, respectively. Women who developed pre-eclampsia had significantly higher A1C values before and during pregnancy compared with women who did not develop pre-eclampsia (P < 0.05, respectively). In early pregnancy, A1C ≥ 8.0% was associated with a significantly increased risk of pre-eclampsia (odds ratio 3.68 [95% CI 1.17-11.6]) compared with optimal control. At 26 weeks' gestation, A1C values ≥ 6.1% (good: 2.09 [1.03-4.21]; moderate: 3.20 [1.47-7.00]; and poor: 3.81 [1.30-11.1]) and at 34 weeks' gestation A1C values ≥ 7.0% (moderate: 3.27 [1.31-8.20] and poor: 8.01 [2.04-31.5]) significantly increased the risk of pre-eclampsia compared with optimal control. The adjusted odds ratios for pre-eclampsia for each 1% decrement in A1C before pregnancy, at the first antenatal visit, at 26 weeks' gestation, and at 34 weeks' gestation were 0.88 (0.75-1.03), 0.75 (0.64-0.88), 0.57 (0.42-0.78), and 0.47 (0.31-0.70), respectively. Glycemic control was not significantly associated with gestational hypertension. CONCLUSIONS: Women who developed pre-eclampsia had significantly higher A1C values before and during pregnancy. These data suggest that optimal glycemic control both early and throughout pregnancy may reduce the risk of pre-eclampsia in women with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In general, specific risks of diabetes in pregnancy include spontaneous abortion, fetal anomalies, preeclampsia, fetal demise, macrosomia, neonatal hypoglycemia, neonatal hyperbilirubinemia, and neonatal respiratory distress syndrome, among others.”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [2]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“In addition, diabetes in pregnancy increases the risks of obesity, hypertension, and type 2 diabetes in offspring later in life (1,2).”
From 15. Management of Diabetes in Pregnancy: Standards of Care in Diabetes—2024 (2024) · cites this paper as [2]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
(2000) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2000.107928 · Cited by 3,270
The Global Impact of Pre-eclampsia and Eclampsia
Duley, L. (2009) · Seminars in Perinatology · doi:10.1053/j.semperi.2009.02.010 · Cited by 2,866
Brown, M. A., Lindheimer, M. D., Swiet, M. D., Assche, A. V., & Moutquin, J.-M. (2001) · Hypertension in Pregnancy · doi:10.1081/prg-100104165 · Cited by 1,894
The Scottish Intercollegiate Guidelines Network (SIGN)
Miller, J. (2002) · The British Journal of Diabetes & Vascular Disease · doi:10.1177/14746514020020010401 · Cited by 1,544
The National Institute for Clinical Excellence (NICE)
Rodgers, A.-T. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii92 · Cited by 966
Hyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group
(2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318187b7a2 · Cited by 488
Outcomes in Type 1 Diabetic Pregnancies
Jensen, D. M., Damm, P., Moelsted-Pedersen, L., Ovesen, P., Westergaard, J. G., Moeller, M., & Beck-Nielsen, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2819 · Cited by 486
Obstetric and Perinatal Outcomes in Type 1 Diabetic Pregnancies
Persson, M., Norman, M., & Hanson, U. (2009) · Diabetes Care · doi:10.2337/dc09-0656 · Cited by 436
Cited by
Items 201–213 of 213
Barikan, J., Hagman, A., Bohlin, L., Elfvin, A., Lindén, K., Dotevall, A., & Englund‐Ögge, L. (2025) · Acta Paediatrica · doi:10.1111/apa.70351
Type 1 Diabetes: During Preconception, Pregnancy, Postpartum, Breastfeeding
Yamamoto, J. M., & Donovan, L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00018-1
Efectos de la diabetes gestacional y su tratamiento sobre el DNA mitocondrial
Alcaraz, S. E. C., Bocanegra, J. G., Bustos, M. D. L. Á. J., Salazar, R. R., González, Á. D. P., Sabanero, G. B., & Monroy, M. L. L. D. L. V. (2025) · JÓVENES EN LA CIENCIA · doi:10.15174/jc.2025.4964
Xie, X. (2020) · Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona)
Differenze di genere nei neonati figli di madri diabetiche
Dessole, F. (2018) · UnissResearch (Università degli Studi di Sassari)
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meissner, T., et al. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-7979
Heart matters: Congenital malformations in infants of diabetic mothers – insights from Kolkata
Jha, S. K., Biswas, P., Halder, D., Roy, A., Ghosh, S., Sardar, S. C. S., Sardar, F. R., & Ali, S. M. (2026) · Asian Journal of Medical Sciences · doi:10.71152/ajms.v17i2.5053
Svébis, M. M., Fazekas‐Pongor, V., Major, D., Pártos, K., Dósa, N., Mészáros, Á., Horváth, V. J., Domján, B. A., Zsirai, L., & Tabák, Á. G. (2025) · Diabetologia Hungarica · doi:10.24121/dh.2025.37
Hummel, M., Füchtenbusch, M., Battefeld, W., Bührer, C., Groten, T., Haak, T., Kainer, F., Kautzky‐Willer, A., Lechner, A., Meißner, T., et al. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01448-9
Bur, R., Danukusumo, D., Putra, M. A. R., Talib, S. R., Pramuktini, S., Safanta, N., Gebrina, M., Dewi, F. E. S., Dharmala, A. B., & Megawulandari, D. (2026) · Acta Medica Bulgarica · doi:10.2478/amb-2026-0041
Syleouni, M., Lee, T. T. M., Carrieri, F., Scott, E. M., Mirón, A. K., & Murphy, H. R. (2026) · Diabetic Medicine · doi:10.1111/dme.70394
Glucose excursions throughout the reproductive life stages in women with diabetes
Knorr, S., Storebjerg, T. M., Kirkegaard, K., Hviid, K. V. R., Nielsen, H. S., & Kampmann, U. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag379
Jahan, S. (2014) · ScholarWorks (Walden University)
Metadata
- Authors
- Holmes, V. A., Young, I. S., Patterson, C. C., Pearson, D. W. M., Walker, J. D., Maresh, M. J. A., McCance, D. R., & for the Diabetes and Pre-eclampsia Intervention Trial Study Group
- Affiliations
- Queen's University Belfast (GB)
- Aberdeen Royal Infirmary (GB)
- St John's Hospital (GB)
- St Mary's Hospital (GB)
- Royal Victoria Hospital (GB)
- Corresponding author
- McCance, David R.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-07-16
- Volume
- 34
- Issue
- 8
- Pages
- 1683-1688
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3142058
- OpenAlex
- W2134759695
- Cited by
- 205
- References
- 26
- Citations by year
- 2026: 7 · 2025: 18 · 2024: 14 · 2023: 21 · 2022: 15 · 2021: 13 · 2020: 16 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 12 · 2015: 17 · 2014: 9 · 2013: 11 · 2012: 6
- FWCI
- 11.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- Wellcome Trust (083145/Z/07/Z, 067028, 210183)
- Queen's University Belfast
- European Foundation for the Study of Diabetes
- Queen's University
- Economic and Social Research Council (ES/G007438/1)
- Centre for Public Health, Queen's University Belfast
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 1 diabetes in pregnancy, preeclampsia, gestational hypertension, glycemic control, HbA1c, pregnancy outcomes, risk factors, preeclampsia prevention, prenatal care, HbA1c targets, HbA1c thresholds, HbA1c monitoring
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Pre-Eclampsia, Pregnancy, Hypertension, Pregnancy-Induced, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.